RS
CRGX

R Squared’s CARGO Therapeutics CRGX Stock Holding History

R Squared’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50
Closed -$721 – 567
2024
Q4 		$721 Buy
+50
New +$907 ﹤0.01% 1525

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return

R Squared's CRGX Position: Q1 2025 in Review

R Squared sold out of CARGO Therapeutics (CRGX) in Q1 2025, closing a stake of 50 shares — an estimated $721 sold.

R Squared first reported a position in CRGX in Q4 2024 and held it in 1 quarter. The position peaked at $721 in Q4 2024. 113 funds tracked by Wall St. Rank hold CRGX as of Q1 2025.

  • R Squared reported no remaining CARGO Therapeutics position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 50 CARGO Therapeutics shares in Q1 2025, an estimated $721.
  • R Squared first reported a position in CARGO Therapeutics in Q4 2024 and held it in 1 quarter.
  • R Squared's CARGO Therapeutics position peaked at $721 in Q4 2024.
  • 113 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.